How many insider declarations has Doyle Janeen Noel filed?

Doyle Janeen Noel has filed 3 public insider declarations with SEC (Form 4).

What is Doyle Janeen Noel's role?

Doyle Janeen Noel's reported role is not specified by the regulator across the filings.

Which companies does Doyle Janeen Noel report trades for?

Doyle Janeen Noel reports trades for Janux Therapeutics, Inc..

What is Doyle Janeen Noel's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 49k€.

← Executives ★ Sign in to follow

DJ

Doyle Janeen Noel

F

·SEC (Form 4)

Janux Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€49,029

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the full record of transactions filed by Doyle Janeen Noel. Insider active across 1 company, notably Janux Therapeutics, Inc.. Aggregated, 3 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €49k. History available since 2 June 2025. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Doyle Janeen Noel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Janux Therapeutics, Inc. (US)

申报3 总计

▼

Doyle Janeen Noel

Chief Corp. & Bus. Dev. Ofcr高管2026年6月2日Janux Therapeutics, Inc.

US$56,94425SEC ↗

4,059 股@ US$14.0290.0059% mcap100.0% 占其流量Common StockSEC:0002069239-26-000005:0

◆

Doyle Janeen Noel

Chief Corp. & Bus. Dev. Ofcr高管2026年1月2日Janux Therapeutics, Inc.

0SEC ↗

36,000 股0Common StockSEC:0002069239-26-000002:0

◆

Doyle Janeen Noel

Chief Corp. & Bus. Dev. Ofcr高管2025年6月2日Janux Therapeutics, Inc.

11SEC ↗

44,000 股0Common StockSEC:0001415889-25-015684:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

DJ

Doyle Janeen Noel

F

·SEC (Form 4)

Janux Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€49,029

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the full record of transactions filed by Doyle Janeen Noel. Insider active across 1 company, notably Janux Therapeutics, Inc.. Aggregated, 3 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €49k. History available since 2 June 2025. The latest transaction was disclosed on 2 June 2026 (Cession). Regulator: SEC (Form 4). All data is free.